Technical Analysis for NKTX - Nkarta, Inc.
Grade | Last Price | % Change | Price Change |
---|---|---|---|
D | 6.82 | -4.88% | -0.35 |
NKTX closed down 4.88 percent on Thursday, April 25, 2024, on 1.51 times normal volume. The price action carved out a bullish hammer (or hammer-like) candlestick pattern. That may indicate an upside reversal. Look for price to trade above the high of the hammer for confirmation. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
Earnings due: May 9
*** please verify all earnings dates ***ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Up | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Hammer Candlestick | Bullish | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
Wide Bands | Range Expansion | -4.88% | |
Oversold Stochastic | Weakness | -4.88% | |
Wide Bands | Range Expansion | -9.79% | |
Oversold Stochastic | Weakness | -9.79% | |
Narrow Range Bar | Range Contraction | -7.71% | |
Inside Day | Range Contraction | -7.71% | |
Wide Bands | Range Expansion | -7.71% |
Alert | Time |
---|---|
60 Minute Opening Range Breakdown | about 11 hours ago |
1.5x Volume Pace | about 12 hours ago |
Down 5% | about 12 hours ago |
Down 3% | about 13 hours ago |
Fell Below Previous Day's Low | about 13 hours ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/09/2024
Nkarta, Inc., a biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the surface of tumor cells. Its co-lead product candidates are NKX101, a pre-clinical product that enhances the power of innate NK biology to detect and kill cancerous cells; and NKX019, a pre-clinical product, which is based on the ability to treat various B cell malignancies by targeting the CD19 antigen found on these types of cancerous cells. The company was founded in 2015 and is headquartered in South San Francisco, California.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Cancer Biology Immune System Immunotherapy Cancer Treatment Tumor Lymphoma Virotherapy Gene Therapy Chimeric Antigen Receptor T Cell Natural Killer Cell Therapies For Cancer Chimeric Antigen Receptor Antigen CD19 Tumor Cell
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Cancer Biology Immune System Immunotherapy Cancer Treatment Tumor Lymphoma Virotherapy Gene Therapy Chimeric Antigen Receptor T Cell Natural Killer Cell Therapies For Cancer Chimeric Antigen Receptor Antigen CD19 Tumor Cell
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 16.24 |
52 Week Low | 1.28 |
Average Volume | 1,027,571 |
200-Day Moving Average | 5.33 |
50-Day Moving Average | 10.49 |
20-Day Moving Average | 8.57 |
10-Day Moving Average | 7.71 |
Average True Range | 0.90 |
RSI (14) | 32.43 |
ADX | 37.08 |
+DI | 11.62 |
-DI | 33.94 |
Chandelier Exit (Long, 3 ATRs) | 9.15 |
Chandelier Exit (Short, 3 ATRs) | 9.16 |
Upper Bollinger Bands | 10.82 |
Lower Bollinger Band | 6.32 |
Percent B (%b) | 0.11 |
BandWidth | 52.49 |
MACD Line | -0.99 |
MACD Signal Line | -0.89 |
MACD Histogram | -0.1006 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 7.62 | ||||
Resistance 3 (R3) | 7.59 | 7.29 | 7.48 | ||
Resistance 2 (R2) | 7.29 | 7.09 | 7.31 | 7.44 | |
Resistance 1 (R1) | 7.06 | 6.97 | 6.91 | 7.09 | 7.39 |
Pivot Point | 6.76 | 6.76 | 6.69 | 6.78 | 6.76 |
Support 1 (S1) | 6.53 | 6.56 | 6.38 | 6.56 | 6.25 |
Support 2 (S2) | 6.23 | 6.44 | 6.25 | 6.20 | |
Support 3 (S3) | 6.00 | 6.23 | 6.16 | ||
Support 4 (S4) | 6.03 |